Pinnacle Wealth Planning Services’s Pacira BioSciences PCRX Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.2K	Sell	1,425 -2,688	-65%	-$63.5K	﹤0.01%	1498
2026 Q1	$93K	Buy	4,113 +87	+2%	+$1.93K	0.01%	841
2025 Q4	$104K	Buy	+4,026	New	+$95.7K	0.01%	759
2021 Q1	–	Sell	-1,589	Closed	-$95K	–	1486
2020 Q4	$95K	Buy	+1,589	New	+$93K	0.02%	490

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pinnacle Wealth Planning Services's PCRX Position: Q2 2026 in Review

Pinnacle Wealth Planning Services reduced its Pacira BioSciences (PCRX) stake by 65% in Q2 2026, selling an estimated $63.5K and leaving 1,425 shares worth $36.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1498.

Pinnacle Wealth Planning Services first reported a position in PCRX in Q4 2020 and has held it in 4 quarters since. The position peaked at $104K in Q4 2025. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Pinnacle Wealth Planning Services held 1,425 shares of Pacira BioSciences worth $36.2K as of Q2 2026.
Pinnacle Wealth Planning Services sold 2,688 Pacira BioSciences shares in Q2 2026, an estimated $63.5K.
Pacira BioSciences made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #1498 holding.
Pinnacle Wealth Planning Services first reported a position in Pacira BioSciences in Q4 2020 and has held it in 4 quarters since.
Pinnacle Wealth Planning Services's Pacira BioSciences position peaked at $104K in Q4 2025.
253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.